338 related articles for article (PubMed ID: 15047705)
1. NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling.
Nho CW; O'Dwyer PJ
J Biol Chem; 2004 Jun; 279(25):26019-27. PubMed ID: 15047705
[TBL] [Abstract][Full Text] [Related]
2. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.
Blonska M; Shambharkar PB; Kobayashi M; Zhang D; Sakurai H; Su B; Lin X
J Biol Chem; 2005 Dec; 280(52):43056-63. PubMed ID: 16260783
[TBL] [Abstract][Full Text] [Related]
3. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.
Blonska M; You Y; Geleziunas R; Lin X
Mol Cell Biol; 2004 Dec; 24(24):10757-65. PubMed ID: 15572679
[TBL] [Abstract][Full Text] [Related]
4. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.
Sakurai H; Suzuki S; Kawasaki N; Nakano H; Okazaki T; Chino A; Doi T; Saiki I
J Biol Chem; 2003 Sep; 278(38):36916-23. PubMed ID: 12842894
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
Grotterød I; Maelandsmo GM; Boye K
BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
[TBL] [Abstract][Full Text] [Related]
8. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.
Yeung KC; Rose DW; Dhillon AS; Yaros D; Gustafsson M; Chatterjee D; McFerran B; Wyche J; Kolch W; Sedivy JM
Mol Cell Biol; 2001 Nov; 21(21):7207-17. PubMed ID: 11585904
[TBL] [Abstract][Full Text] [Related]
9. Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C.
Yao KS; O'Dwyer PJ
Biochem Pharmacol; 1995 Jan; 49(3):275-82. PubMed ID: 7857313
[TBL] [Abstract][Full Text] [Related]
10. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.
Buss H; Dörrie A; Schmitz ML; Hoffmann E; Resch K; Kracht M
J Biol Chem; 2004 Dec; 279(53):55633-43. PubMed ID: 15489227
[TBL] [Abstract][Full Text] [Related]
11. The essential role of MEKK3 in TNF-induced NF-kappaB activation.
Yang J; Lin Y; Guo Z; Cheng J; Huang J; Deng L; Liao W; Chen Z; Liu Z; Su B
Nat Immunol; 2001 Jul; 2(7):620-4. PubMed ID: 11429546
[TBL] [Abstract][Full Text] [Related]
12. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression.
Huang WC; Chen JJ; Chen CC
J Biol Chem; 2003 Mar; 278(11):9944-52. PubMed ID: 12645577
[TBL] [Abstract][Full Text] [Related]
13. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.
Mattioli I; Sebald A; Bucher C; Charles RP; Nakano H; Doi T; Kracht M; Schmitz ML
J Immunol; 2004 May; 172(10):6336-44. PubMed ID: 15128824
[TBL] [Abstract][Full Text] [Related]
14. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway.
Takaesu G; Surabhi RM; Park KJ; Ninomiya-Tsuji J; Matsumoto K; Gaynor RB
J Mol Biol; 2003 Feb; 326(1):105-15. PubMed ID: 12547194
[TBL] [Abstract][Full Text] [Related]
15. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
16. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
17. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
[TBL] [Abstract][Full Text] [Related]
18. CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation.
Hong X; Xu L; Li X; Zhai Z; Shu H
FEBS Lett; 2001 Jun; 499(1-2):133-6. PubMed ID: 11418127
[TBL] [Abstract][Full Text] [Related]
19. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
